Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-23

FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA approved a supplemental application for the generic Losartan Potassium and Hydrochlorothiazide from Solco Healthcare US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan potassium and hydrochlorothiazide (losartan potassium and hydrochlorothiazide)

Snippet

SUPPL AP for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)